ArticleMolecular imaging and biology2017
[
Article in Molecular imaging and biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 30 citations in OpenAlex.
- Nuclear medicine imaging for bone metastases assessment: what else besides bone scintigraphy in the era of personalized medicine?Frontiers in medicine · 2023Review
- StagingEuropean journal of nuclear medicine and molecular imaging · 2022Article
- Exosomes derived from PC-3 cells suppress osteoclast differentiation by downregulating miR-148a and blocking the PI3K/AKT/mTOR pathway.Experimental and therapeutic medicine · 2021Article
- Comparison ofCancers · 2021Article
- Novel PET imaging methods for prostate cancer.World journal of urology · 2021Review
- Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings.Cancer imaging : the official publication of the International Cancer Imaging Society · 2020Review
- Performance ofEuropean journal of nuclear medicine and molecular imaging · 2020Article
- Comparison of [European journal of nuclear medicine and molecular imaging · 2018Article
- Uptake of Radium-223 Dichloride and Early [Molecular imaging and biology · 2018Article
- Advances in prostate-specific membrane antigen PET of prostate cancer.Current opinion in oncology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to evaluate potential differences in "Glu-NH-CO-NH-Lys" radio-labeled with [ PROCEDURES: This retrospective study was approved by the local ethics committee. Patients who received [
resultsOne hundred fifty-four bone metastases in 30 patients were evaluated. Eighty out of 154 (51.9%) metastases were classified as OB, 21/154 (13.6%) as OL, 23/154 (14.9%) as M, and 30/154 (19.5%) as BM. The SUV
conclusions[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.